company background image
EWL logo

Edwards Lifesciences DB:EWL Stock Report

Last Price

€85.62

Market Cap

€51.7b

7D

0.1%

1Y

15.0%

Updated

26 Mar, 2024

Data

Company Financials +

Edwards Lifesciences Corporation

DB:EWL Stock Report

Market Cap: €51.7b

EWL Stock Overview

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally.

EWL fundamental analysis
Snowflake Score
Valuation0/6
Future Growth3/6
Past Performance3/6
Financial Health6/6
Dividends0/6

Rewards

Risk Analysis

EWL passed our risk checks.

Edwards Lifesciences Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Edwards Lifesciences
Historical stock prices
Current Share PriceUS$85.62
52 Week HighUS$86.88
52 Week LowUS$57.10
Beta1.05
1 Month Change5.34%
3 Month Change23.37%
1 Year Change15.02%
3 Year Change22.61%
5 Year Change51.74%
Change since IPO6,164.88%

Recent News & Updates

Recent updates

Shareholder Returns

EWLDE Medical EquipmentDE Market
7D0.1%-1.2%1.9%
1Y15.0%4.3%7.3%

Return vs Industry: EWL exceeded the German Medical Equipment industry which returned 2.8% over the past year.

Return vs Market: EWL exceeded the German Market which returned 6.4% over the past year.

Price Volatility

Is EWL's price volatile compared to industry and market?
EWL volatility
EWL Average Weekly Movement5.6%
Medical Equipment Industry Average Movement5.0%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.1%
10% least volatile stocks in DE Market2.4%

Stable Share Price: EWL has not had significant price volatility in the past 3 months.

Volatility Over Time: EWL's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
195819,800Bernard Zovighianhttps://www.edwards.com

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve.

Edwards Lifesciences Corporation Fundamentals Summary

How do Edwards Lifesciences's earnings and revenue compare to its market cap?
EWL fundamental statistics
Market cap€51.72b
Earnings (TTM)€1.29b
Revenue (TTM)€5.54b

40.1x

P/E Ratio

9.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EWL income statement (TTM)
RevenueUS$6.00b
Cost of RevenueUS$1.38b
Gross ProfitUS$4.63b
Other ExpensesUS$3.22b
EarningsUS$1.40b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)2.33
Gross Margin77.02%
Net Profit Margin23.35%
Debt/Equity Ratio8.9%

How did EWL perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.